CHARACTERIZING THE MECHANISM OF QUETIAPINE DISTRIBUTION IN LIPID-CORE NANOCAPSULES PSEUDO-PHASES USING A VALIDATED LC/UV METHOD

CHARACTERIZING THE MECHANISM OF QUETIAPINE DISTRIBUTION IN LIPID-CORE NANOCAPSULES PSEUDO-PHASES USING A VALIDATED LC/UV METHOD

Quetiapine is an atypical antipsychotic used to treat schizophrenia. However, despite great interest for its chronic therapeutic use, quetiapine has some important side effects such as weight gain induction. The development of a quetiapine nanocarrier can potentially target the drug into central ner...

Full description

Bibliographic Details
Main Authors:	Fernando Carreño, Karina Paese, Carolina de Miranda Silva, Sílvia S. Guterres, Teresa Dalla Costa
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Química 2015-11-01
Series:	Química Nova
Subjects:	quetiapine lipid core nanocapsules HPLC/UV analytical method validation
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422015000901181&lng=en&tlng=en

Similar Items

Lipid core nanocapsules-loaded tacrolimus: Development and evaluation of quality parameters
by: Graziela Scheuer Gomes, et al.
Published: (2022-07-01)

LC-MS/MS method applied to preclinical pharmacokinetic investigation of olanzapine-loaded lipid-core nanocapsules
by: Frantiescoli A. Dimer, et al.
Published: (2014-01-01)

A study of photodegradation of quetiapine by the use of LC-MS/MS method
by: Skibiński Robert
Published: (2012-02-01)

DRY-POWDER OF CHITOSAN-COATED LIPID-CORE NANOCAPSULES CONTAINING DAPSONE: DEVELOPMENT, LASER DIFFRACTION CHARACTERIZATION AND ANALYTICAL QUANTIFICATION
by: Rodrigo Cé, et al.
Published: (2019-07-01)

A set of synthetic data, antibacterial evaluation and bacterial interaction with lipid-core nanocapsules containing fusidic acid
by: Rodrigo Cé, et al.
Published: (2021-06-01)

Quetiapine Addiction: A Case Report
by: A. Chaara, et al.
Published: (2022-06-01)

Estabilização do ácido lipoico via encapsulação em nanocápsulas poliméricas planejadas para aplicação cutânea Stabilization of lipoic acid by encapsulation in polymeric nanocapsules designed for cutaneous administration
by: Irene Clemes Külkamp, et al.
Published: (2009-01-01)

The Anti-Arthritic Activity of Diclofenac Lipid-Core Nanocapsules: Stereological Analysis Showing More Protection of Deep Joint Components
by: Nathalie Marte Ureña, et al.
Published: (2023-07-01)

Hesperetin-loaded lipid-core nanocapsules in polyamide: a new textile formulation for topical drug delivery
by: Menezes PP, et al.
Published: (2017-03-01)

A Review of Priapism Associated with Quetiapine
by: Davood Hosseini Talari, et al.
Published: (2019-03-01)

Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery: in vitro and ex vivo evaluation
by: Rania S. Abdel-Rashid, et al.
Published: (2022-12-01)

TITRIMETRIC AND SENSITIVE SPECTRO-PHOTOMETRIC METHODS FOR THE ASSAY OF QUETIAPINE FUMARATE IN PHARMACEUTICAL FORMULATIONS
by: Nagaraju Rajendraprasad, et al.
Published: (2011-03-01)

Melatonin-loaded lipid-core nanocapsules protect against lipid peroxidation caused by paraquat through increased SOD expression in Caenorhabditis elegans
by: Mariele F. Charão, et al.
Published: (2019-12-01)

Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin
by: Hale Ünal, et al.
Published: (2015-02-01)

Quetiapine-induced priapism
by: Murat Eren Ozen, et al.
Published: (2018-06-01)

Development of nanocapsule suspensions and nanocapsule spray-dried powders containing melatonin
by: Schaffazick Scheila R., et al.
Published: (2006-01-01)

Comparison of tolerability between quetiapine and haloperidol in schizophrenia
by: Naba Raj Koirala, et al.
Published: (2012-12-01)

Quetiapine-induced hyponatremia in elderly
by: Shiva Shanker Reddy Mukku, et al.
Published: (2018-01-01)

Development and physicochemical characterization of dexamethasone-loaded polymeric nanocapsule suspensions
by: Rossana Barcellos Friedrich, et al.
Published: (2008-01-01)

The Occurrence of Priapism as a Result of the Use of a Single Dose of Quetiapine
by: Fatih Ozkaya, et al.
Published: (2012-08-01)

Overdose of Quetiapine—A Case Report with QT Prolongation
by: Elisabetta Bertol, et al.
Published: (2021-12-01)

Role of poly(ε-caprolactone) lipid-core nanocapsules on melanoma–neutrophil crosstalk
by: Drewes CC, et al.
Published: (2017-09-01)

Switching to quetiapine for risperidone-induced amenorrhea: Report of two cases
by: P K Pardal, et al.
Published: (2010-01-01)

Oral Treatment of Spontaneously Hypertensive Rats with Captopril-Surface Functionalized Furosemide-Loaded Multi-Wall Lipid-Core Nanocapsules
by: Cecilia B. Michalowski, et al.
Published: (2020-01-01)

The Pharmacogenetics of Treatment with Quetiapine
by: María Ortega-Ruiz, et al.
Published: (2022-07-01)

Coma Blisters in the Setting of Quetiapine Overdose: Case Report and Review of Literature
by: Timothy Wiegand, et al.
Published: (2013-12-01)

Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells
by: Michelli B. Antonow, et al.
Published: (2017-12-01)

Recurrent Priapism from Therapeutic Quetiapine
by: Omeed Saghafi, et al.
Published: (2014-02-01)

Quetiapine-induced bicytopenia. Case report and literature review
by: T. Gutiérrez Higueras, et al.
Published: (2021-04-01)

Drug-Induced Secondary Hypertension by Quetiapine Prescription in an Elderly Patient with Anxiety Disorder
by: Reza Bidaki, et al.
Published: (2022-12-01)

Quetiapine-induced Priapism Requiring Frequent Emergency Admissions: A Case Report
by: Jon C. Jackson, et al.
Published: (2015-01-01)

Dextran Nanocapsules with <i>ω</i>-3 in Their Nucleus: An Innovative Nanosystem for Imiquimod Transdermal Delivery
by: Gisela F. Carreño, et al.
Published: (2022-11-01)

A retrospective record review and assessment of cost of quetiapine use in a community psychiatric setting in the Sedibeng district of Gauteng
by: Lesley J. Robertson, et al.
Published: (2017-07-01)

Neuroleptic malignant syndrome induced by concomitant use of risperidone and quetiapine
by: Mustafa Volkan Demir, et al.
Published: (2016-01-01)

Efficacy and tolerability of clozapine versus quetiapine in treatment-resistant schizophrenia
by: Mitesh Kumar, et al.
Published: (2017-01-01)

Quetiapine-Induced Severe Hypoglycemia in Patient Without Diabetes Mellitus: A Case Report
by: Suk Ju Cho, et al.
Published: (2019-03-01)

Delirium Induced by Quetiapine and the Potential Role of Norquetiapine
by: Filipe Almeida, et al.
Published: (2019-08-01)

Detection and identification of atypical quetiapine metabolite in urine
by: Atanasov Vasil, et al.
Published: (2008-09-01)

Study on influence of polymer and surfactant on in vitro performance of biodegradable aqueous-core nanocapsules of tenofovirdisoproxil fumarate by response surface methodology
by: Grandhi Srikar, et al.

False positive ketamine urine immunoassay screen result induced by quetiapine: A case report
by: Chun-Hao Liu, et al.
Published: (2017-09-01)